208 related articles for article (PubMed ID: 36838971)
1. Integrating Siderophore Substructures in Thiol-Based Metallo-β-Lactamase Inhibitors.
Rotter MJ; Zentgraf S; Weizel L; Frank D; Burgers LD; Brunst S; Fürst R; Proschak A; Wichelhaus TA; Proschak E
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838971
[TBL] [Abstract][Full Text] [Related]
2. Approved Drugs Containing Thiols as Inhibitors of Metallo-β-lactamases: Strategy To Combat Multidrug-Resistant Bacteria.
Klingler FM; Wichelhaus TA; Frank D; Cuesta-Bernal J; El-Delik J; Müller HF; Sjuts H; Göttig S; Koenigs A; Pos KM; Pogoryelov D; Proschak E
J Med Chem; 2015 Apr; 58(8):3626-30. PubMed ID: 25815530
[TBL] [Abstract][Full Text] [Related]
3. Hydroxyhexylitaconic acids as potent IMP-type metallo-β-lactamase inhibitors for controlling carbapenem resistance in
Wachino J-i; Jin W; Norizuki C; Kimura K; Tsuji M; Kurosaki H; Arakawa Y
Microbiol Spectr; 2024 Mar; 12(3):e0234423. PubMed ID: 38315122
[TBL] [Abstract][Full Text] [Related]
4. Sulfamoyl Heteroarylcarboxylic Acids as Promising Metallo-β-Lactamase Inhibitors for Controlling Bacterial Carbapenem Resistance.
Wachino JI; Jin W; Kimura K; Kurosaki H; Sato A; Arakawa Y
mBio; 2020 Mar; 11(2):. PubMed ID: 32184250
[TBL] [Abstract][Full Text] [Related]
5. Nitroxoline and its derivatives are potent inhibitors of metallo-β-lactamases.
Proschak A; Martinelli G; Frank D; Rotter MJ; Brunst S; Weizel L; Burgers LD; Fürst R; Proschak E; Sosič I; Gobec S; Wichelhaus TA
Eur J Med Chem; 2022 Jan; 228():113975. PubMed ID: 34865870
[TBL] [Abstract][Full Text] [Related]
6. Diversity and Proliferation of Metallo-β-Lactamases: a Clarion Call for Clinically Effective Metallo-β-Lactamase Inhibitors.
Somboro AM; Osei Sekyere J; Amoako DG; Essack SY; Bester LA
Appl Environ Microbiol; 2018 Sep; 84(18):. PubMed ID: 30006399
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and enzyme-based evaluation of analogues
Khalili Arjomandi O; Kavoosi M; Adibi H
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1414-1425. PubMed ID: 31401901
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and in vitro and biological evaluation of potent amino acid-derived thiol inhibitors of the metallo-β-lactamase IMP-1.
Arjomandi OK; Hussein WM; Vella P; Yusof Y; Sidjabat HE; Schenk G; McGeary RP
Eur J Med Chem; 2016 May; 114():318-27. PubMed ID: 27017264
[TBL] [Abstract][Full Text] [Related]
9. Thiol-Containing Metallo-β-Lactamase Inhibitors Resensitize Resistant Gram-Negative Bacteria to Meropenem.
Tehrani KHME; Martin NI
ACS Infect Dis; 2017 Oct; 3(10):711-717. PubMed ID: 28820574
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic Investigations of Metallo-β-lactamase Inhibitors: Strong Zinc Binding Is Not Required for Potent Enzyme Inhibition*.
Wade N; Tehrani KHME; Brüchle NC; van Haren MJ; Mashayekhi V; Martin NI
ChemMedChem; 2021 May; 16(10):1651-1659. PubMed ID: 33534956
[TBL] [Abstract][Full Text] [Related]
11. In Vitro and In Vivo Development of a β-Lactam-Metallo-β-Lactamase Inhibitor: Targeting Carbapenem-Resistant
Peters BK; Reddy N; Shungube M; Girdhari L; Baijnath S; Mdanda S; Chetty L; Ntombela T; Arumugam T; Bester LA; Singh SD; Chuturgoon A; Arvidsson PI; Maguire GEM; Kruger HG; Naicker T; Govender T
ACS Infect Dis; 2023 Mar; 9(3):486-496. PubMed ID: 36786013
[TBL] [Abstract][Full Text] [Related]
12. 4-(
Gavara L; Verdirosa F; Legru A; Mercuri PS; Nauton L; Sevaille L; Feller G; Berthomieu D; Sannio F; Marcoccia F; Tanfoni S; De Luca F; Gresh N; Galleni M; Docquier JD; Hernandez JF
Biomolecules; 2020 Jul; 10(8):. PubMed ID: 32717907
[TBL] [Abstract][Full Text] [Related]
13. Broad-Spectrum Inhibitors against Class A, B, and C Type β-Lactamases to Block the Hydrolysis against Antibiotics: Kinetics and Structural Characterization.
Farhat N; Gupta D; Ali A; Kumar Y; Akhtar F; Kulanthaivel S; Mishra P; Khan F; Khan AU
Microbiol Spectr; 2022 Oct; 10(5):e0045022. PubMed ID: 36069578
[TBL] [Abstract][Full Text] [Related]
14. Challenges in the Development of a Thiol-Based Broad-Spectrum Inhibitor for Metallo-β-Lactamases.
Büttner D; Kramer JS; Klingler FM; Wittmann SK; Hartmann MR; Kurz CG; Kohnhäuser D; Weizel L; Brüggerhoff A; Frank D; Steinhilber D; Wichelhaus TA; Pogoryelov D; Proschak E
ACS Infect Dis; 2018 Mar; 4(3):360-372. PubMed ID: 29172434
[TBL] [Abstract][Full Text] [Related]
15. Relative inhibitory activities of the broad-spectrum β-lactamase inhibitor taniborbactam against metallo-β-lactamases.
Le Terrier C; Viguier C; Nordmann P; Vila AJ; Poirel L
Antimicrob Agents Chemother; 2024 Feb; 68(2):e0099123. PubMed ID: 38047644
[TBL] [Abstract][Full Text] [Related]
16. In Silico Fragment-Based Design Identifies Subfamily B1 Metallo-β-lactamase Inhibitors.
Cain R; Brem J; Zollman D; McDonough MA; Johnson RM; Spencer J; Makena A; Abboud MI; Cahill S; Lee SY; McHugh PJ; Schofield CJ; Fishwick CWG
J Med Chem; 2018 Feb; 61(3):1255-1260. PubMed ID: 29271657
[TBL] [Abstract][Full Text] [Related]
17. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
[TBL] [Abstract][Full Text] [Related]
18. Structural and biochemical analysis of the metallo-β-lactamase L1 from emerging pathogen Stenotrophomonas maltophilia revealed the subtle but distinct di-metal scaffold for catalytic activity.
Kim Y; Maltseva N; Wilamowski M; Tesar C; Endres M; Joachimiak A
Protein Sci; 2020 Mar; 29(3):723-743. PubMed ID: 31846104
[TBL] [Abstract][Full Text] [Related]
19. ZN148 Is a Modular Synthetic Metallo-β-Lactamase Inhibitor That Reverses Carbapenem Resistance in Gram-Negative Pathogens
Samuelsen Ø; Åstrand OAH; Fröhlich C; Heikal A; Skagseth S; Carlsen TJO; Leiros HS; Bayer A; Schnaars C; Kildahl-Andersen G; Lauksund S; Finke S; Huber S; Gjøen T; Andresen AMS; Økstad OA; Rongved P
Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32179522
[TBL] [Abstract][Full Text] [Related]
20. An updated patent review of metallo-β-lactamase inhibitors (2020-2023).
Denakpo E; Naas T; Iorga BI
Expert Opin Ther Pat; 2023; 33(7-8):523-538. PubMed ID: 37737836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
